Torsade de pointes associated with very-high-dose methadone.
about
QTc interval screening for cardiac risk in methadone treatment of opioid dependenceECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addictsSublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trialA systematic review of the cardiotoxicity of methadoneMethadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-upTrends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry dataVentricular dysrhythmias associated with poisoning and drug overdose: a 10-year review of statewide poison control center data from California.Cocaine-related torsade de pointes in a methadone maintenance patient.Syncope and wide QRS tachycardia.Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.Brief review: anesthetic implications of long QT syndrome in pregnancy.Cardiac side effects of psychiatric drugs.Itraconazole-induced torsade de pointes in a patient receiving methadone substitution therapy.Buprenorphine as a safe alternative to methadone in a patient with acquired long QT syndrome: a case report.Evaluation of QTc interval in Iranian causalities (Janbazan) of Iran-Iraq war receiving maintenance methadone treatment.Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.Methadone deaths: risk factors in pain and addicted populations.QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients.Pharmacotherapy in the treatment of addiction: methadone.Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.A modeling and simulation approach to characterize methadone QT prolongation using pooled data from five clinical trials in MMT patients.Sudden death in an adult taking methadone: lessons for general practiceClinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain.Drug-induced long QT syndromeTorsades de pointes associated with methadone and voriconazole.Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir.Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus.Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.Clinical pharmacology of methadone for pain.The role of methadone in cancer pain treatment--a review.Methodology for the Randomised Injecting Opioid Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK.Methadone induced torsades de pointes and ventricular fibrillation: A case review.QTc interval screening in an opioid treatment program.Clinical relevance and management of drug-related QT interval prolongation.Methadone-Associated Prolongation of the QTc Interval at Doses Used for Chronic Pain.
P2860
Q24201880-FDA7EBDF-2B31-4E2C-993E-83FA7BCA0B55Q24235379-D9CA2440-EB20-407D-A246-EBEA33FC7362Q24647455-3C8A2F5A-9C4C-4E74-A4C7-64C10D5968B6Q26766513-15258096-36CB-4156-949E-93C6F0B60D0CQ28257915-F219955F-72C2-42B3-BE46-7D86BE14C37EQ30629456-A9BC3989-A872-45D5-AB95-56284DBB2CF5Q30883223-C077C20E-992D-4DAA-A94D-5506B3E9998AQ33152447-922543A9-8110-4FD6-8A89-A9DB7C99360EQ33152895-B522AF23-1A4B-40C1-A75B-1E839B6150E2Q33154871-FC798701-6823-46C1-B6DA-841F76FB0C3EQ33155299-C34A1AB1-1041-4C24-8438-1A79F9748D96Q33155805-22C12E37-18BC-4B09-8F8B-74381CFD385EQ33158078-DEBF568B-C082-4A92-B38B-81698E63167CQ33160587-AF770669-ECBE-4D57-8964-43ABD9C163D0Q33162180-20E2472D-599C-465B-890F-D7BC8409B86AQ33166593-699C30DA-28C7-4A88-B74A-3400899D9BE5Q33687681-B648FF63-F4D3-4FA4-B9E3-47213FBDEF47Q33705809-5F3C04A3-3C0F-4328-A5AE-1603744C0B93Q33742582-54C35E08-AE16-4D04-AFFF-9B0A21ECBBB3Q33835424-E7D250F3-5AA4-4EC2-AF16-F4379B62599FQ33870389-72142A20-8079-434B-A6C5-3AEF55118DCEQ33878154-E1802863-F07B-4076-A946-A347BF6EDCEFQ33914167-F7C032D4-9567-4B3E-8BB8-251DF92B06ECQ34100661-031F12B1-3760-49CD-886B-4EA030062254Q34129646-58DC86AA-E8E7-4083-B9BE-177F87AACC13Q34179339-47AF50C8-1896-4E8F-9003-DE96CF15A5EEQ34223794-24E6472D-3A5A-4A13-9C42-AECCFB8B0CDBQ34274116-82987CC8-CAB3-424B-B608-77733418911CQ34358104-D840E85A-F152-4480-9E58-C2E4D8EAC42FQ34527805-B63D80EA-95CB-4A27-8C5A-B088018C3322Q34578756-1A004B21-D6D2-4E68-BAF1-BDC1D1439829Q34606790-162CDD67-6A14-40A8-92A9-6706F0F35723Q34608182-8D853E8A-7048-462C-8002-FC2902B930B3Q34760432-538D38B8-C539-439B-B878-4B6A61DD5A82Q34990113-A59B91C6-02A8-45B1-945C-7DD414911DA9Q35094562-84FEB512-A0ED-4A5D-8BEE-743A7FBEE53AQ35160624-8B0D6A63-AF96-4CB4-AAFA-23F55211C0F1Q35180735-5B34E03E-A5D5-4EB9-B3A4-49A845801302Q35186542-EBF21885-4AAF-42EE-8E14-D53716305994Q35283546-F0418224-73FF-4260-9899-B34DDBC11263
P2860
Torsade de pointes associated with very-high-dose methadone.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Torsade de pointes associated with very-high-dose methadone.
@ast
Torsade de pointes associated with very-high-dose methadone.
@en
Torsade de pointes associated with very-high-dose methadone.
@nl
type
label
Torsade de pointes associated with very-high-dose methadone.
@ast
Torsade de pointes associated with very-high-dose methadone.
@en
Torsade de pointes associated with very-high-dose methadone.
@nl
prefLabel
Torsade de pointes associated with very-high-dose methadone.
@ast
Torsade de pointes associated with very-high-dose methadone.
@en
Torsade de pointes associated with very-high-dose methadone.
@nl
P2093
P1476
Torsade de pointes associated with very-high-dose methadone.
@en
P2093
Alastair D Robertson
Helen Hays
Laurent Lewkowiez
Mary Ann Woodroffe
Mori J Krantz
Philip S Mehler
P304
P356
10.7326/0003-4819-137-6-200209170-00010
P407
P577
2002-09-01T00:00:00Z